Interstitial Lung Dz Flashcards

Objectives

1
Q

Interstitial Lung Dz

A
  • A broad category of chronic lung diseases that includes >130 disorders characterized by scarring of the lungs and/or inflammation of the lungs.
  • Cancer and infectious causes must be ruled out.
  • Broadly classified into Idiopathic Pulmonary Pneumonias and Non-Idiopathic Interstitial Pulmonary Fibrosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ILD Pathophys

A
  • Common pathophysiology is thought to have begun with an acute injury to the lung parenchyma leading to chronic interstitial inflammation. Then fibroblast activation and proliferation results in pulmonary fibrosis and tissue destruction.
  • Usually insidious in onset but can be acute and rapidly progressive.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ILD clinical presentation

A
  • Most common is dyspnea on exertion (DOE).
  • Chronic non-productive cough.
  • Clubbing of the nails.
  • Often found as abnormal CXR on routine exam.
  • Hemoptysis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ILD Hx

A

Very important in order to appropriately diagnose the problem.

  • Thorough occupational history (e.g. asbestos, silica, heavy metals, moldy foliage, farming,) environmental (pigeon breeding, hot tub, ventilation systems/ humidifiers).
  • Drug history. WHAT HAVE YOU TAKEN? amiodarone that we give for afib, commonly causes interstitial disease
  • Smoking history.
  • Family history.
  • Risk factors for immunosuppression.

Pay close attention to the onset and duration of symptoms, the rate of disease progression and associated symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ILD PE

A
  • May be very limited or normal
  • Possible wheezing
  • Digital clubbing
  • Possible S3 gallop which represents cor pulmonale
  • Pedal edema
  • Possible lymphadenopathy in sarcoidosis
  • Cutaneous or articular findings in rheumatologic diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ILD Non-invasive Testing

A
  • Lab tests (findings usually non-specific)
    • Routine: CBC with diff, ESR, CMP, U/A, ABG
  • Disease specific:
    • ANA for SLE
    • rheumatoid factor for RA
    • antineutrophil cytoplasmic antibodies for Wegener’s granulomatosis
    • anti-basement membrane antibodies for Goodpasture’s syndrome
  • CXR
    • Reticular and nodular opacities are the hallmark, normal findings in 10% of patients. Other diseases have specific CXR characteristics
  • CT Scan
    • Linear reticular opacities are the most common finding. Disease specific characteristics have allowed for radiographic diagnosis in >50% of cases.
  • Pulmonary function tests (PFTs)
    • Typical finding is of a restrictive pattern with decreased diffusion capacity.
    • Your DLCO will be reduced in patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Invasive Testing

A
  • Bronchoscopy with BAL and TBBx
    • Bronchoalveolar lavage (BAL)
      • Not required for diagnosis but can help to rule out other diseases.
    • Transbronchial biopsy (TBBx)
      • Often of limited value because inadequate sampling
      • Can help to rule out other diseases.
  • Many patients require open or thoracoscopic lung biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Histopathology

A
  • Histopathology is widely varied.
  • Sent to speciality lung referral center for bx
  • Interpretation is difficult and there can be disagreement between pathologists.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ILD Classification: Idiopathic Pulmonary Pneumonias

A
  • Idiopathic pulmonary fibrosis (IPF)
  • Nonspecific interstitial pneumonia (NSIP)
  • Desquamative interstitial pneumonia (DIP)
  • Respiratory bronchiolitis interstitial lung disease (RBILD)
  • Acute interstitial pneumonia (AIP)Cryptogenic organizing pneumonia
  • Lymphoid interstitial pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ILD Classification: Non-Idiopathic Interstitial Pulmonary Fibrosis

A
  • Associated with environmental or occupational exposure
  • Associated with Rheumatologic/ connective tissue disorder
  • Associated with drug exposure
  • Sarcoidosis and other granulomatous lung diseases
  • Associated with other systemic diseases
  • inherited lung dz
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Idiopathic Pulmonary Pneumonias

A
  • A group of disorders that have a common clinical, radiographic and physiologic characteristics with no defined cause.
  • Known causes of interstitial lung disease must be ruled out.
  • Characterized by varying degrees of fibrosis and/or inflammation that effects the interstitium to a greater degree than the airways or alveoli.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Idiopathic Pulmonary Pneumonias: Idiopathic pulmonary fibrosis (IPF)

A
  • 50-60% of IPPs
  • CT- great extent of honeycombing of lung and no ground glass appearance;
  • Lung biopsy shows histologic pattern called usual interstitial pneumonia (UIP)
  • Progressive lung dysfunction with fatal outcome despite aggressive treatment with steroids and immunosuppressive therapy (azathioprine)
  • Lung transplant has best survival data.
  • Median survival 3-5 years from dx with or without treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Idiopathic Pulmonary Pneumonias: Nonspecific interstitial pneumonia (NSIP)

A
  • Often associated with or looks like collagen vascular diseases or hypersensitivity pneumonitis
  • CT shows predominance of ground glass attenuation
  • Prognosis generally better than IPF
  • Prognosis: NSIP > IPF
  • CT: ground class NSIP vs no ground glass and honey combing IPF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Idiopathic Pulmonary Pneumonias: Respiratory bronchiolitis interstitial lung disease (RBILD)

A
  • Almost always associated with chronic and current smoking
  • Usually occurs in 4th -5th decade
  • PFTs – varying degrees of airway obstruction with only mildly decrease or normal total lung capacity and decreased DLCO
  • BAL- numerous brown pigmented alveolar macrophages. Think smoker’s fingers are brown
  • Histology- pigmented alveolar macrophages with glassy eosinophilic cytoplasm and granular pigmentation within respiratory bronchioles. Honeycombing NOT present
  • Prognosis is good with smoking cessation. Must stop smoking.

*occasionally needs steroids, short burst, short duration, secondary to EXTREME sensitivity to cigarette smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Idiopathic Pulmonary Pneumonias: Lymphoid interstitial pneumonia

A
  • Very rare
  • Look for concurrent collagen vascular disease
  • Variable prognosis with steroid treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Idiopathic Pulmonary Pneumonias: Desquamative interstitial pneumonia (DIP)

A
  • Very rare
  • Most pts are smokers
  • Outcome generally good with stopping smoking and oral steroids.
  • 70% survive 10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Idiopathic Pulmonary Pneumonias: Acute interstitial pneumonia (AIP)

A
  • Seen in otherwise healthy persons immediately after apparent viral illness.
  • Rare but serious disease characterized by diffuse alveolar damage with subsequent fibrosis.
  • 70% fatal in 3 months.
  • Also called Hamman-Rich syndrome.
  • Management is largely supportive.
  • Histologically indistinguishable from ARDS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Idiopathic Pulmonary Pneumonias: Cryptogenic organizing pneumonia

A

*Previously referred to as a Bronchiolitis Obliterans Organizing Pneumonia (BOOP)

  • Commonly manifest as a flu-like illness with non-productive cough followed by exertional dyspnea.
  • Most are current or past smokers
  • CT shows airspace consolidation (organizing pneumonoia) and lower lung zone predominance often with ground glass appearance
  • BAL: non –specific
  • Histology—excessive proliferation of granulation tissue within small airways and chronic inflammation in the
  • Most recover completely with oral corticosteroids but may relapse after cessation and require long term steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis

A
  • Associated with environmental or occupational exposure to dust (pneumoconiosis, hypersensitivity pneumonitis)
  • Associated with Rheumatologic/ connective tissue disorder
  • Associated with drug exposure
  • Sarcoidosis and other granulomatous lung diseases
  • Associated with other systemic diseases
  • Inherited lung diseases
  • Associated with environmental or occupational exposure (these pts also have a high smoking rate that may confound their occupational exp
20
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis: Pneumoconiosis

A
  • occupational lung disease related to inhalation exposure to inorganic dusts
  • Pneumoconiosis can be classified as fibrotic or non-fibrotic
    • Coal worker’s pneumoconiosis (Black lung)
      • Progressive massive fibrosis can be a complication
    • Asbestosis
      • Exposed workers in asbestos mining, mfg. of asbestos products
    • Silicosis
      • Associated with crystalline silica exposure primarily in mining of granite, slate, and sandstone
    • Berylliosis
      • Lithonia industries in Atlanta area
      • Associated with beryllium (rare metal) exposure in high tech industry and fluorescent light mfg.
    • Byssinosis (Cotton worker’s lung)
21
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis: Hypersensitivity Pneumoconiosis

A
  • inflammation of the alveoli secondary to repeated inhalation of organic dusts, think come from plants or animals ex: poison ivy can cause a hypersensitivty reaction
  • (AKA extrinsic allergic alveolitis)
  • Over 300 etiologies
    • Farmer’s lung (moldy hay)
    • Bird fancier’s lung (bird and rodent droppings)
    • Woodworkers lung (Mold wood)
    • Chemical workers lung
  • Treat the same with steroids, NOT infectious, it’s the inflammation from inhaling those particles
22
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis: Associated with Rheumatologic / Connective tissue diseases

A
  • Treat underlying disease
    • Scleroderma
    • Rheumatoid Arthritis (RA)
    • Systemic Lupus Erythmatosus (SLE)
    • Progressive Systemic Sclerosis
    • Dermatomyositis / Polymyositis
23
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis: Medication Induced

A
  • More than 300 drugs can cause ILD with varied radiographic findings and presentations.
    • Cytotoxic agents
      • bleomycin
      • methotrexate
    • Antibiotics
      • Nitrofurantoin also used for UTI
      • sulfasalazine
    • Antiarrhythmics
      • amiodorone
    • Anti-inflammatory
      • gold
      • pennicillamine
    • Illicit drugs
      • Crack, cocaine
      • heroine
24
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis: Pulmonary vasculitides

A
  • Wegener’s Granulomatosis –see on boards, although unusual
  • Goodpasture syndrome –see on boards, although unusual
  • Churg-Strauss Syndrome
  • Idiopathic Pulmonary Capillaritis
25
Q

Non-Idiopathic Interstitial Pulmonary Fibrosis: Wegener’s Granulomatosis

A
  • Rare multisystem autoimmune disease of unknown etiology
    • 0.5 cases per 100,000 people
    • More common in northern European descent
    • Rare in blacks
  • Hallmark features: necrotizing granulomatous inflammation and pauci-immune vasculitis in small and medium sized blood vessels most commonly in Resp tract and Kidneys
  • Positive Cytoplasmic - Antineutrophil Cytoplasmic Antibody (C-ANCA)
  • Possible genetic predisposition with inciting factor.
26
Q

Wegener’s Granulomatosis Clinical Presentation

A
  • Wide spectrum of clinical presentation with chronic nonspecific constitutional symptoms e.g. fever, night sweats, fatigue, decreased appetite, weight loss
  • Opthalmic
    • Conjunctivitis, uveitis, optic nerve vasculitis, proptosis
  • ENT – chronic sinusitis most common initial complaint (67%)
  • Pulm – may be asymp, slow onset, or severe and sudden with infiltrates (71%), cough(34%), hemoptysis(18%), Dyspnea/SOB (7%)
  • Arthralgias in small and large joints common
  • Renal involvement (17%) and usually asymptomatic
    • May see microscopic blood in urine
  • Late peripheral nervous system involvement common (67%)
  • Skin – 45% show involvement with palpable purpura or skin ulcers
27
Q

Wegener’s Granulomatosis – Diagnostics

A
  • routine lan test non-specific
    • inc BUN & Creat
    • mild normochromic normocytic anemia
    • inc ESR & CRP
    • Protein on U/A
  • More specific are ANCA tests with proper clinical suspicion
  • CXR abnl 66% with single or multiple nodules and masses often cavitated
  • Perform baseline PFT’s
  • Bronchoscopy
  • Biopsy
28
Q

Wegener’s Granulomatosis- Tx

A
  • Combo of corticosteroids and cytotoxic agents (cyclophophamide). Untreated 90% mortality in 2 yrs
  • Current treatment recommendations in WG depend on the severity and activity of disease.
    • Localized - Upper and/or lower respiratory tract disease without any other systemic involvement or constitutional symptoms
    • Early systemic - Any, without organ-threatening or life-threatening disease
    • Generalized - Renal or other organ-threatening disease, serum creatinine level less than 5.6 mg/dL
    • Severe - Renal or other vital-organ failure, serum creatinine level exceeding 5.6 mg/dL
    • Refractory - Progressive disease unresponsive to glucocorticoids and cyclophosphamide
29
Q

Pulmonary vasculitides: Goodpasture syndrome

A
  • autoimmune disorder with diffuse pulmonary hemorrhage and acute or rapidly progressive glomerulonephritis and the presence of circulating anti-glomerular basement membrane (anti-GBM) antibodies
  • Likely genetic component
    • Rare 0.5 cases per 1,000,000 people
30
Q

Goodpasture syndrome symptoms

A
  • Constitutional symptoms - malaise, chills and fever, and/or arthralgias may precede or be concurrent with pulmonary or renal manifestations
  • Hemoptysis is the presenting symptom when the disease affects the lungs. The level of hemoptysis may vary and, in a small percentage of patients, may be absent. Other pulm sx include cough, dyspnea, and shortness of breath
  • Massive pulmonary hemorrhage leading to respiratory failure may occur
  • Chest pain is present in less than half of the patients
  • Renal manifestations include hematuria, edema, high blood pressure and eventually uremia
  • Significant anemia may result from persistent intrapulmonary bleeding
31
Q

Goodpasture syndrome – Differentials

A
  • Churg-Strauss Syndrome
  • Essential Mixed Cryoglobulinemia
  • Glomerulonephritis, Acute
  • Henoch-Schönlein Purpura
  • Microscopic Polyarteritis
  • Pneumocystis Carinii Pneumonia
  • Pneumonia, Community-Acquired
  • Respiratory Failure
  • Rheumatoid Arthritis
  • Undifferentiated Connective-Tissue Disease
  • Wegener Granulomatosis
32
Q

Goodpasture syndrome – Physical exam

A
  • Tachypnea
  • Inspiratory crackles over lung bases
  • Cyanosis
  • Hemoptysis
  • Hepatosplenomegaly (may be present)
  • Hypertension (present in 20% of cases)
  • Rash
  • Edema
33
Q

Goodpasture syndrome – Diagnostics

A
  • U/A - low grade proteinuria, gross or microscopic hematuria
  • CBC – anemia secondary to bleeding
  • BUN and Creat elevated secondary to renal dysfunction
  • Anti-GBM antibodies
  • ANCA tests
  • CXR shows patchy parenchymal consolidations which resolves and progresses into an interstitial pattern with repeated hemorrhage
  • Biopsy – Renal preferred over lung if possible
34
Q

Goodpasture syndrome – Treatment

A

The 3 principles of therapy in anti–glomerular basement membrane (anti-GBM) disease

  1. Rapidly remove circulating antibody, primarily by plasmapheresis
  2. Stop further production of antibodies using immunosuppression with medications
  3. Remove offending agents that may have initiated the antibody production
35
Q

Inherited diseases are rare

Know that these diseases are INHERITED!

A
  • Tuberous sclerosis
  • Neurofibromatosis
  • Niemann-Pick disease
  • Gaucher’s disease
36
Q

Sarcoidosis

A
  • Sarcoidosis is a multisystem inflammatory disease of unknown etiology that predominantly affects the lungs and intrathoracic lymph nodes. Sarcoidosis is manifested by the presence of noncaseating granulomas (NCGs) in affected organ tissues.
  • Unknown Cause: however, both genetic and environmental factors seem to play a role. As yet, no bacterial, fungal, or viral antigen has been consistently isolated from the sarcoidosis lesions. Sarcoidosis is neither a malignant nor an autoimmune disease.
37
Q

Sarcoidosis clinical course and stats

A
  • The clinical course is variable and ranges from asymptomatic disease with spontaneous resolution to progressive multisystem disease with resulting death.
  • Overall mortality <5%
  • M:F 2:1
  • Incidence peak 25-35, with second peak in women at 45-65
  • In U.S. affects blacks>whites but worldwide whites account for 80% of patients.
38
Q

Sarcoidosis History and physical

A
  • depends on the extent and severity of the organs involved.
  • Systemic complaints, fever, anorexia, and arthralgias occur in 45% of cases.
  • Pulmonary, dyspnea on exertion (biggest complaint), cough, chest pain, and hemoptysis (rare) occur in 50% of cases
    • Pulmonary findings
      • Usually normal but may be significant for crackles
      • Exertional oxygen desaturation also may be found.
39
Q

sarcoidosis, clinical staging is based on the chest radiograph

A
  • Stage 0: Normal chest radiograph
  • Stage I: Hilar and mediastinal lymph node enlargement
  • Stage II: Lymphadenopathy and parenchymal disease
  • Stage III: Parenchymal disease only
  • Stage IV: Pulmonary fibrosis
40
Q

Sarcoidosis: Dermatological manifestations

A
  • Erythema nodosum may occur.
  • Violaceous rash often seen on cheeks or nose
41
Q

Sarcoidosis: Ocular manifestation

A
  • Anterior or posterior granulomatous uveitis is most frequent.
  • Conjunctival lesions and scleral plaques may also be noted.
  • Ocular involvement may lead to blindness if untreated
42
Q

Sarcoidosis: Cardiac manifestations

A
  • Heart failure from cardiomyopathy rarely occurs.
  • Heart block and sudden death may occur
43
Q

sarcoidosis: diagnostics

A
  • Labs
    • Routine lab evaluation often is unrevealing.
    • An elevated alkaline phosphatase level suggests hepatic involvement. Although liver involvement is common, it rarely is clinically relevant.
    • Angiotensin converting enzyme (ACE) levels may be elevated.
  • A chest radiograph is central to evaluation. Sarcoidosis
  • Diagnosis requires biopsy in most cases.
  • Some asymptomatic patients who do not require treatment and only have bilateral hilar lymphadenopathy (BHL) may be monitored without a biopsy.
  • Transbronchial biopsy (TBB) via fiberoptic bronchoscope is often done.
    • The yield is high.
    • Results may be positive, even in the setting of normal CXR findings.
  • Endobronchial biopsy is done during bronchoscopy and increases the yield of the procedure.
  • If therapy is to be given for sarcoidosis, tissue confirmation is essential. Watchful waiting is indicated only for patients who exhibit a classic presentation, are asymptomatic, and can ensure close follow-up
44
Q

Sarcoidosis tx decision

A
  • Few reliable studies on disease indications and optimal treatment exist.
  • Most patients (>75%) require only symptomatic therapy (nonsteroidal anti-inflammatory drugs). Approximately 10% of patients need treatment for extrapulmonary disease, while 15% of patients require treatment for persistent pulmonary disease.
45
Q

sarcoidosis: surgical care tx

A
  • For patients with advanced sarcoid-induced pulmonary fibrosis, lung transplantation remains the only hope for long-term survival
  • Lung transplantation is a viable option for patients with stage IV sarcoidosis. Transplantation in such patients should be strongly considered when the forced vital capacity falls below 50% predicted and/or the forced expiratory volume in 1 second falls below 40% predicted
46
Q

Sarcoidosis: meds tx

A
  • Corticosteroids are the mainstay of therapy.
  • Generally, prednisone given daily and then tapered over a 6-month course is adequate for pulmonary disease. Most patients who require long-term steroids can be treated using 10-15 mg of prednisone every other day.
  • Recent data suggest that corticosteroid use may be associated with increased relapse rates.
  • Occasionally, certain patients cannot tolerate or do not respond to corticosteroids.
  • Noncorticosteroid agents are being used more frequently. Common indications for the initiation of such agents include steroid-resistant disease, intolerable adverse effects, or patient desire not to take corticosteroids.
  • Methotrexate (MTX) has been a successful alternative to prednisone and is a steroid-sparing agent.
    • For extrapulmonary sarcoidosis involving such critical organs as the heart, liver, eyes, kidneys, or central nervous system, corticosteroid therapy is indicated.